Literature DB >> 6225580

Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii.

J B de Souza, J H Playfair.   

Abstract

The anti-lymphocyte autoantibody response to irradiated lethal Plasmodium berghei malaria parasites in normal mice was significantly reduced when recipients were pre-treated with splenic T cells from mice recovered from a non-lethal Plasmodium yoelii infection. Suppression was specific for the autoantibody and did not affect the antibody response to the parasite. Experiments involving sequential P. yoelii-P. berghei infections in situ revealed that recovery from P. berghei was possible when the interval between the two infections was 14 days or more. This ability to recover from P. berghei correlated with a progressive reduction of anti-lymphocyte autoantibody suggesting a useful role for the suppressor cell. The possible link between suppressor cells and anti-lymphocyte autoantibodies in malaria is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6225580      PMCID: PMC1536195     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  T-cell activation in murine malaria.

Authors:  A N Jayawardena; G A Targett; E Leuchars; R L Carter; M J Doenhoff; A J Davies
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

2.  Chronic malarial infection in Balb/C mice. Effect on the immune response to sheep erythrocytes and histological changes in the liver and spleen.

Authors:  N Wedderburn; J L Turk; M S Hutt
Journal:  Trans R Soc Trop Med Hyg       Date:  1975       Impact factor: 2.184

3.  Induction of thymocytotoxic autoantibodies after injection of bacterial lipopolysaccharides in mice.

Authors:  S Izui; T Kobayakawa; J Louis; P H Lambert
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

Review 4.  Immunological circuits: cellular composition.

Authors:  H Cantor; R K Gershon
Journal:  Fed Proc       Date:  1979-06

5.  Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei.

Authors:  J H Playfair; J B De Souza; B J Cottrell
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

6.  Depletion of T and B lymphocytes during malarial infections.

Authors:  A U Krettli; R Nussenzweig
Journal:  Cell Immunol       Date:  1974-09       Impact factor: 4.868

7.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

8.  Immunofluorescence method suitable for large-scale application to malaria.

Authors:  A Voller; P O'Neill
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

9.  Cell-mediated immunity in mice vaccinated against malaria.

Authors:  B J Cottrell; J H Playfair; B J De Souza
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

10.  Loss of circulating T lymphocytes with normal levels of B and 'null' lymphocytes in Thai adults with malaria.

Authors:  R A Wells; K Pavanand; S Zolyomi; B Permpanich; R P MacDermott
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

View more
  4 in total

1.  Anti-lymphocyte autoantibodies in lethal mouse malaria and their absence in an irradiation-induced non-lethal variant.

Authors:  S Waki; G A Targett; J B De Souza; J H Playfair
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

2.  Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.

Authors:  J B De Souza; K H Williamson; T Otani; J H Playfair
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  Serum IL-2 inhibitor in mice. I. Increase during infection.

Authors:  R Lelchuk; J H Playfair
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

4.  Partial cross-reactivity by suppressor cells induced during different experimental autoimmune diseases.

Authors:  J H Playfair; J B De Souza; P R Hutchings; A Cooke
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.